Tillomed

Generic Pharmaceuticalstillomed.com

Tillomed is a UK-based pharmaceutical company that develops, licenses, and markets a portfolio of 100-plus generic medicines to wholesalers across the UK and continental Europe through subsidiaries in Spain, Italy, and Germany.

Company typePrivate
Founded1991
HeadquartersLuton, United Kingdom
Headcount51–100
GTM typeB2B
OfferingHardware or Manufacturing

Tillomed firmographics

Firmographics

Name: Tillomed
Legal name: Tillomed Laboratories Ltd.
Website: https://tillomed.com
Company type: Private
Founded year: 1991
Operating status: Operating
Headcount range: 51–100 employees
Short description: Tillomed is a UK-based pharmaceutical company that develops, licenses, and markets a portfolio of 100-plus generic medicines to wholesalers across the UK and continental Europe through subsidiaries in Spain, Italy, and Germany.
Ownership category
akta.pro rank

Tillomed industry classification

Industry

Product category: Generic Pharmaceuticals
NAICS: Pharmaceutical and Medicine Manufacturing (3254)
SIC: Pharmaceutical Preparations (2834)
akta.pro primary industry: Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
akta.pro secondary industries: Oral Solid Dose (OSD) Generics (HLAIABAD), Oncology Specialty Pharmaceuticals (HLAIACAA)

Keywords

Generic pharmaceuticals
Pharmaceutical product licensing
Injectable formulations
Oral solid dose
Pharmaceutical wholesale supply

Where Tillomed is headquartered

Location

Headquarters

HQ city: Luton
HQ country: United Kingdom
HQ region: Europe

Offices2 records

Markets served

Tillomed business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

Pharmaceutical Product Sales: Tillomed generates revenue through the development, licensing, and marketing of high-quality generic pharmaceuticals to wholesalers in the UK and Europe. The company has grown from €5m in 2013 to €100m business in 2020, indicating strong revenue growth through product sales.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Tillomed product offering

Product offering

Core offering

Tillomed develops, licenses and markets a portfolio of over 100 generic pharmaceutical products in multiple dosage forms (oral solid dose and injectables) across therapy areas including oncology, cardiovascular, anti-infectives, anti-epileptics, gastro-intestinal, immunosuppressants, mental health, analgesia, women's health, genito-urinary and osteoporosis. Its products are supplied predominantly to pharmaceutical wholesalers in the UK and Europe under MHRA and Home Office licensing.

Product overview

Tillomed is a pharmaceutical company offering a portfolio of 109 generic pharmaceutical products across multiple dosage forms including oral solid dose and injectables. The company specializes in development, licensing, and marketing of high-quality generic medications. Their therapeutic areas include oncology (e.g., Azacitidine, Carmustine, Busulfan), cardiovascular (e.g., Labetalol, Amlodipine, Propranolol), anti-infectives (e.g., Ceftazidime, Moxifloxacin), anti-epileptics (e.g., Gabapentin, Pregabalin), gastro-intestinal (e.g., Esomeprazole, Loperamide), immunosuppressants (e.g., Mycophenolate Mofetil, Azathioprine), mental health (e.g., Duloxetine), analgesia (e.g., Ketoprofen), women's health, genito-urinary, and osteoporosis. Tillomed is owned by Emcure Pharma and operates with subsidiaries in Spain, Italy, and Germany.

Differentiator

Problem solved

Functional benefit

Products and services

Amikacin Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Azacitidine Oncology generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Azathioprine Immunosuppressant generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Betacap Branded generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Busulfan Oncology generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Carbimazole Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Carmustine Oncology generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Caspofungin Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Ceftazidime Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Ceftriaxone Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Cidofovir Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe, and the subject of a non-interventional post-authorisation safety study.
Cinacalcet Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Clotrimazole Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Co-Amlodipine Cardiovascular generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Co-Trimoxazole Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Dapsone Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Darunavir Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Duloxetine Mental health generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Esomeprazole Gastro-intestinal generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Famotidine Gastro-intestinal generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Febuxostat Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Felodipine (Pinefeld) Cardiovascular branded generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Flecainide Cardiovascular generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Fludrocortisone Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Gabapentin Anti-epileptic generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Gemfibrozil Cardiovascular generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Isosorbide Mononitrate (Eumon) Cardiovascular branded generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Ketoprofen (Tiloket) Analgesia branded generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Labetalol Cardiovascular generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Leflunomide Immunosuppressant generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Loperamide Gastro-intestinal generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Melphalan Oncology generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Metformin Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Midodrine Cardiovascular generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Moxifloxacin Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Mycophenolate Mofetil Immunosuppressant generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Nabumetone Analgesia generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Nifedipine (Valni) Cardiovascular branded generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Nitrofurantoin Anti-infective generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Oxazepam Mental health generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Oxybutynin Genito-urinary generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Perindopril Cardiovascular generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Pregabalin Anti-epileptic generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Propranolol (Beta Prograne) Cardiovascular branded generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Propranolol (Half Beta Prograne) Cardiovascular branded generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Rizatriptan Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Solifenacin Succinate Genito-urinary generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Sotalol Cardiovascular generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Tamoxifen Oncology generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Tranexamic Acid Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Treosulfan Oncology generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Treprostinil Cardiovascular generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Trientine Dihydrochloride Generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Verapamil (Veratil) Cardiovascular branded generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.
Zoledronic Acid Osteoporosis/oncology generic pharmaceutical product in Tillomed's portfolio, supplied to wholesalers in the UK and Europe.

Quantifiable outcome

Revenue growth from €5m (2013) to €100m (2020)
+2 more outcomes

Companies that use Tillomed

Customer profile

Segments1 record

Ideal customer profiles1 record

Tillomed technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Tillomed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

Emcure Pharma UK LtdcoreStrategic or Co-development PartnerTillomed is a wholly owned subsidiary of Emcure Pharma UK Ltd. Emcure is a privately held company with a strong track record of launching high quality, innovative medicines. Emcure researches, develops, manufactures, and markets high-quality, cost-effective, differentiated pharmaceutical products and has a world-class manufacturing infrastructure with facilities across India and the USA.

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Tillomed competitors and assessment

Company assessment

Direct peers

KRKA: KRKA is a Slovenia-headquartered European generic pharmaceutical company marketing a diverse portfolio across multiple therapy areas via wholesale channels; comparable to Tillomed in mid-size, EU-focused, multi-therapy generics with OSD and injectable formats.
Ennogen Pharma: Ennogen is a UK-headquartered generic pharmaceutical company marketing a broad generic portfolio to wholesalers and healthcare providers, closely comparable to Tillomed in size, geographic focus on the UK/EU, and B2B wholesale distribution model.
Accord Healthcare: Accord Healthcare is a UK-based generic pharmaceuticals company (part of Intas Pharmaceuticals) supplying generic medicines across multiple therapy areas including oncology to wholesalers across Europe, directly comparable to Tillomed's model, scale, and channel.
Zentiva: Zentiva is a major European generics manufacturer and marketer headquartered in Prague, supplying generic pharmaceuticals across multiple therapy areas throughout the EU; directly comparable to Tillomed in product breadth, channel, and EU geographic focus.

Broad incumbents

Dr. Reddy's Laboratories: Dr. Reddy's is a large India-based generic pharmaceutical company with established European operations and a specialty generics portfolio including oncology injectables, comparable to Tillomed's Emcure-backed model and product mix.
Sandoz (Novartis): Sandoz is the global #1 generics company with a dominant European presence across multiple therapy areas including oncology; comparable to Tillomed as the broad incumbent in the same generic pharma space that Tillomed operates in.
Glenmark Pharmaceuticals: Glenmark Pharmaceuticals is an India-headquartered generics and specialty company with European presence, supplying a broad generic portfolio to wholesalers; comparable to Tillomed in vertical integration with Indian manufacturing and EU commercialization.
Teva Pharmaceutical Industries: Teva is the world's largest generic drug manufacturer with extensive European operations, providing direct overlap with Tillomed's generic portfolio across therapy areas and its wholesale-led go-to-market approach.
Aurobindo Pharma: Aurobindo Pharma is an India-headquartered global generics manufacturer with a large European commercial footprint through wholly owned subsidiaries, comparable to Tillomed as an Indian-parent generics platform serving the UK and EU wholesale channel.

Emerging players

Morningside Healthcare: Morningside is a UK-based specialty pharmaceutical company supplying generic and specialty medicines through UK and European wholesalers, directly comparable to Tillomed as a smaller UK-headquartered competitor with overlapping therapy areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Tillomed compliance and trust

Trust signal

Compliance4 records

Tillomed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Tillomed leadership team

Management profile

Number of profiles

Profiles1 record

Tillomed subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Tillomed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Tillomed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tillomed

What does Tillomed do?

Is Tillomed a public or private company?

Tillomed is a private company. It is classified as corporate owned and is currently operating.

When was Tillomed founded?

Tillomed was founded in 1991. It employs 51 to 100 people.

Where is Tillomed based?

Tillomed is headquartered in Luton, United Kingdom, in the Europe region.

How does Tillomed make money?

One revenue line is on record: pharmaceutical Product Sales.

Who are Tillomed's main competitors?

Direct peers on record are KRKA, Ennogen Pharma, Accord Healthcare and Zentiva. Broad incumbents are Dr. Reddy's Laboratories, Sandoz (Novartis), Glenmark Pharmaceuticals, Teva Pharmaceutical Industries and Aurobindo Pharma. Morningside Healthcare is listed as an emerging player.

Does Tillomed have an API?

No public API is recorded for Tillomed.

What industry is Tillomed in?

Tillomed's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIABAD, Oral Solid Dose (OSD) Generics. Its NAICS code is 3254 and its SIC code is 2834.